Sphere Fluidics
https://www.spherefluidics.com
Sphere Fluidics is a life sciences company, based in Cambridgeshire, UK and New Jersey, USA. Sphere Fluidics offers a novel platform (Cyto-Mine®) that performs single cell analysis.
Cyto-Mine® reduces costs for biopharmaceutical discovery and development. It is being adapted to single cell engineering using synthetic biology or genome editing.
In the media
4th December 2018
The Scientist Journal Announces Its Top 10 Innovations Of 2018
1) Cyto-Mine (Sphere Fluidics) - This new single-cell technology allows researchers to screen up to 40 million cells for a desired property, such as specific antibody secretion, and to then dispense and
2nd December 2018
Announcing the Winners of The Scientist's Top 10 Innovations of 2018
1) Cyto-Mine (Sphere Fluidics) – This new single-cell technology allows researchers to screen up to 40 million cells for a desired property, such as specific antibody secretion, and to then dispense and image
1st December 2018
Announcing the Winners of The Scientist's Top 10 Innovations of 2018
1) Cyto-Mine (Sphere Fluidics) – This new single-cell technology allows researchers to screen up to 40 million cells for a desired property, such as specific antibody secretion, and to then dispense and image